Pune, India

Rohan Mahadev Shinde

This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rohan Mahadev Shinde. Retrieved from https://idiyas.com/inventor/rohan-mahadev-shinde

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rohan Mahadev Shinde: Innovator in Cannabinoid Research

Introduction

Rohan Mahadev Shinde is a notable inventor based in Pune, India. He has made significant contributions to the field of cannabinoid research, focusing on the modulation of cannabinoid receptors. His innovative work aims to address various diseases and disorders associated with these receptors.

Latest Patents

Rohan holds a patent for "Cannabinoid receptor modulators - Compounds of Formula (I) along with processes for their preparation." This patent is particularly useful for treating, managing, and lessening diseases, disorders, syndromes, or conditions associated with the modulation of cannabinoid (CB) receptors. The methods outlined in his patent provide valuable insights into the treatment of conditions linked to these receptors.

Career Highlights

Rohan is currently employed at Lupin, Inc., where he continues to advance his research in cannabinoid modulation. His work has garnered attention for its potential impact on therapeutic applications. With 1 patent to his name, Rohan is establishing himself as a key figure in this innovative field.

Collaborations

Some of Rohan's coworkers include Seema Prabhakar Zade and Venkata Poornapragnacharyulu Palle. Their collaborative efforts contribute to the ongoing research and development in cannabinoid therapies.

Conclusion

Rohan Mahadev Shinde is an emerging inventor whose work in cannabinoid receptor modulation holds promise for future medical advancements. His dedication to research and innovation is paving the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…